ACRS Q4 2019 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

Q4 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1M-70.2% YoY

Gross Profit

$68,0006.2% margin

Operating Income

-$18M-1603.0% margin

Net Income

-$19M-1698.1% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

+11.4%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$21M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$98M

Total Liabilities

$28M

Stockholders' Equity

$70M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$4M	-70.2%
Gross Profit	$68,000	$160,000	-57.5%
Operating Income	-$18M	-$39M	+55.0%
Net Income	-$19M	-$39M	+51.8%

Revenue Segments

Laboratory Research Revenue

$1M100%